Latest Medication News

European Executive Vice- President Margrethe Vestager speaks during a media conference regarding an antitrust case at EU headquarters in Brussels, Thursday, Nov. 26, 2020. The European Union has fined two pharmaceutical companies for colluding to keep a cheap alternative to a sleep disorder medicine off the market for their profit and at the expense of patients. (Johanna Geron, Pool via AP)

EU fines drug makers for keeping cheap medicine off market

Nov. 26, 2020 9:23 AM EST

BRUSSELS (AP) — The European Union has fined two pharmaceutical companies for colluding to keep a cheap alternative to a sleep disorder medicine off the market for their profit and at the expense of patients. EU antitrust commissioner, Margrethe Vestager, said that Teva pharmaceuticals and Cephalon, a...

A nurse walks COVID-19 tests back to the tent at the free COVID-19 testing site on Monday, Nov. 23, 2020 in Glenwood Springs, Colo. (Chelsea Self/Glenwood Springs Post Independent via AP)

The Latest: China reports results of mass testing

Nov. 23, 2020 10:56 PM EST

BEIJING — China has reported new coronavirus cases in the cities of Shanghai and Tianjin as it seeks to prevent small outbreaks from becoming larger ones. The National Health Commission said Tuesday that there were two new locally spread cases in the previous 24-hour period, one in each city. It also...

In this undated photo issued by the University of Oxford, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)

3rd major COVID-19 vaccine shown to be effective and cheaper

Nov. 23, 2020 2:44 PM EST

LONDON (AP) — Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world. The results are based on an interim analysis of trials...

In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. The Food and Drug Administration on Saturday, Nov. 21, 2020 authorized the use of the Regeneron Pharmaceuticals Inc. drug to try to prevent patients with mild-to-moderate disease from worsening and needing hospitalization. It's given as a one-time treatment through an IV and is still going through more testing to establish its safety and effectiveness.  (Regeneron via AP)

FDA allows emergency use of antibody drug Trump received

Nov. 21, 2020 11:53 PM EST

U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month. The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc....

FILE - In this Sept. 22, 2020, file photo Housing and Urban Development Secretary Ben Carson speaks to reporters after touring the Plymouth Place senior housing facility in Des Moines, Iowa. Carson is crediting unapproved, experimental treatments with saving his life after saying he became “desperately ill” following his infection with the coronavirus. There is no medical evidence that the treatments Carson cites in a statement on his personal Facebook page worked. (AP Photo/Charlie Neibergall, File)

Carson says he's 'out of the woods' after battling COVID-19

Nov. 21, 2020 7:13 PM EST

STERLING, Va. (AP) — Housing Secretary Ben Carson is crediting unapproved, experimental treatments with saving his life after he became “desperately ill” following his infection with the coronavirus. There is no medical evidence that the treatments Carson cited worked. A retired...

In this Feb. 12, 2019 photo, Meghan Waldron walks down the street in Boston. Waldron is a student at Emerson College with progeria, one of the world's rarest diseases. The first treatment has been approved for progeria, Friday, Nov. 20, 2020.  The U.S. Food and Drug Administration on Friday approved Zokinvy which was shown in testing to extend patients’ lives by 2 ½ years on average.  (Suzanne Kreiter/The Boston Globe via AP)

1st drug for rare rapid-aging disease extends kids' lives

Nov. 20, 2020 7:06 PM EST

The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives. Kids with the genetic disorder progeria typically die in their early teens, usually from heart disease. But in testing, children taking the drug...

President Donald Trump speaks during a news conference in the briefing room at the White House in Washington, Friday, Nov. 20, 2020. (AP Photo/Susan Walsh)

Trump makes late-term bid to lower prescription drug costs

Nov. 20, 2020 5:38 PM EST

WASHINGTON (AP) — Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs. But in a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal...

FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Zsolt Czegledi/MTI via AP, File)

Health experts clash over use of certain drugs for COVID-19

Nov. 20, 2020 12:39 AM EST

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying...

In this March 2, 2020, photo provided by Naomi Worcester, a crew of workers unload gear as they arrive on Kure Atoll in the Northwestern Hawaiian Islands, one of the most remote places on Earth. Cut off from the rest of the planet since February, four environmental field workers are back, re-emerging into a changed society by the coronavirus outbreak. (Naomi Worcester/Hawaii Department of Land and Natural Resources via AP)

The Latest: Hawaii imposes new COVID-19 travel restrictions

Nov. 19, 2020 11:18 PM EST

HONOLULU — Anyone flying to Hawaii will be required to have a negative COVID-19 test result prior to their departure for the state, with the new rule going into effect two days before Thanksgiving, Gov. David Ige announced Thursday. Until now, passengers flying to the islands using a pre-travel testing...

FILE - In this Oct. 1, 2020 file photo, an Amazon logo appears on an Amazon delivery van, in Boston. Amazon opened an online pharmacy Tuesday, Nov. 17 giving shoppers the chance to buy their medication and order refills on their phones and computers and have it delivered to their doorsteps in a couple of days. (AP Photo/Steven Senne, File)

Amazon opens online pharmacy, shaking up another industry

Nov. 17, 2020 6:05 PM EST

NEW YORK (AP) — Now at Amazon.com: insulin and inhalers. The retail colossus opened an online pharmacy Tuesday that allows customers to order medication or prescription refills, and have them delivered to their front door in a couple of days. The potential impact of Amazon's arrival in the pharmaceutical...